PV
Highly rated in
8
conditions
Highly rated in
8
conditions

About Dr. Patrick Van Bogaert

Patrick Van Bogaert is in Antwerpen, Belgium. Dr. Van Bogaert is highly rated in 8 conditions, according to our data. His top areas of expertise are Landau-Kleffner Syndrome, Continuous Spike-Wave During Slow Sleep Syndrome, Epilepsy, and Benign Rolandic Epilepsy.

His clinical research consists of co-authoring 113 peer reviewed articles in the past 15 years.

Locations
  Antwerpen, VLG, BE
Background & Education
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


113 Total Publications

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published —January 18, 2021
CACNA1A-associated epilepsy: Electroclinical findings and treatment response on seizures in 18 patients.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
Antwerp University Hospital
 
Antwerpen, VLG, BE 
 0.1 km
Sven Francque is in Antwerpen, Belgium. They have been an author on 148 peer reviewed articles and participated in 12 clinical trials in the past 15 years.
Highly rated in
0
conditions
University Of Antwerp And Antwerp University Hospital
 
Antwerpen, VLG, BE 
 0.1 km
Geert Mortier is in Antwerpen, Belgium. They have been an author on 166 peer reviewed articles in the past 15 years.
Highly rated in
0
conditions
University Of Antwerp
 
Antwerpen, VLG, BE 
 0.1 km
Peter De Deyn is in Antwerpen, Belgium. They have been an author on 462 peer reviewed articles and participated in 1 clinical trial in the past 15 years.